Skip to main content
Top
Published in: Journal of General Internal Medicine 2/2018

01-02-2018 | Editorial

Taking an Interdisciplinary Approach to Understanding and Improving Medication Adherence

Authors: Kenneth G. Saag, MD, MSc, Smita Bhatia, MD, MPH, Michael J. Mugavero, MD, MHSc, Jasvinder A. Singh, MD, MPH

Published in: Journal of General Internal Medicine | Issue 2/2018

Login to get access

Excerpt

The World Health Organization defines adherence as “the extent to which a person’s behavior—taking medication, following a diet, and/or executing lifestyle changes—corresponds with agreed recommendations from a health care provider.” While adherence research has focused primarily upon multiple dimensions related to taking medications in a manner congruent with prescriber recommendations, other aspects of the broader definition of adherence, including utilization of medical care and engagement in self-care behaviors, have received increasing attention in recent years. Moreover, with greater emphasis on patient-centered care and shared decision making between consumers of care and their health care provider(s), the pejorative term compliance has fallen out of favor and has been replaced nearly universally with the term adherence. Also, although adherence has traditionally focused upon medications used to manage long-term, chronic conditions (e.g., hypertension, diabetes, heart disease, rheumatic conditions), analogous principles are germane and have been applied to curable medical conditions (e.g., cancer, tuberculosis, hepatitis C virus infection). …
Literature
1.
go back to reference Krueger KP, Berger BA, Felkey B. Medication adherence and persistence: a comprehensive review. Adv Ther. 2005;22(4):313–56.CrossRefPubMed Krueger KP, Berger BA, Felkey B. Medication adherence and persistence: a comprehensive review. Adv Ther. 2005;22(4):313–56.CrossRefPubMed
5.
go back to reference Sokol MC, McGuigan KA, Verbrugge RR, Epstein RS. Impact of medication adherence on hospitalization risk and healthcare cost. Med Care. 2005;43(6):521–30.CrossRefPubMed Sokol MC, McGuigan KA, Verbrugge RR, Epstein RS. Impact of medication adherence on hospitalization risk and healthcare cost. Med Care. 2005;43(6):521–30.CrossRefPubMed
8.
go back to reference Stirratt, MJ, Curtis JR, Danila MI, Hansen R, Miller MJ, Gakumo CA. Advancing the science and practice of medication adherence. J Gen Intern Med. [4198]. Stirratt, MJ, Curtis JR, Danila MI, Hansen R, Miller MJ, Gakumo CA. Advancing the science and practice of medication adherence. J Gen Intern Med. [4198].
9.
go back to reference McQuaid EL, Landier W. Cultural issues in medication adherence: disparities and directions. J Gen Intern Med. [4199]. McQuaid EL, Landier W. Cultural issues in medication adherence: disparities and directions. J Gen Intern Med. [4199].
10.
go back to reference Amico KR, Krousel-Wood M, Bosworth HB, Merlin JS. Advantages to using social-behavioral models of medication adherence in research and practice. J Gen Intern Med. [4197]. Amico KR, Krousel-Wood M, Bosworth HB, Merlin JS. Advantages to using social-behavioral models of medication adherence in research and practice. J Gen Intern Med. [4197].
Metadata
Title
Taking an Interdisciplinary Approach to Understanding and Improving Medication Adherence
Authors
Kenneth G. Saag, MD, MSc
Smita Bhatia, MD, MPH
Michael J. Mugavero, MD, MHSc
Jasvinder A. Singh, MD, MPH
Publication date
01-02-2018
Publisher
Springer US
Published in
Journal of General Internal Medicine / Issue 2/2018
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-017-4215-7

Other articles of this Issue 2/2018

Journal of General Internal Medicine 2/2018 Go to the issue

Clinical Practice: Exercises in Clinical Reasoning

Pivot and Cluster: An Exercise in Clinical Reasoning

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine